Homocysteine and lipid peroxidation products: important atherosclerosis risk factors in renal allograft recipients?
Serafinowicz
A
A
Warsaw School of Medicine, Warsaw, Poland.
Kukuła
K
K
Cieciura
T
T
Shaibani
B
B
Baczkowska
T
T
Soin
J
J
Sadowska
A
A
Nowacka-Cieciura
E
E
Lewandowska
D
D
Rell
K
K
Durlik
M
M
Lao
M
M
D000328:Adult; D000447:Aldehydes / Q000097:blood; D001161:Arteriosclerosis / Q000453:epidemiology*; D015415:Biomarkers / Q000097:blood; D001794:Blood Pressure; D005260:Female; D005500:Follow-Up Studies; D005919:Glomerular Filtration Rate; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D016030:Kidney Transplantation / Q000502:physiology*; D015227:Lipid Peroxidation; D008054:Lipid Peroxides / Q000097:blood*; D008297:Male; D008315:Malondialdehyde / Q000097:blood; D011183:Postoperative Complications / Q000453:epidemiology; D012307:Risk Factors; D013997:Time Factors
D000447:Aldehydes; D015415:Biomarkers; D008054:Lipid Peroxides; D006710:Homocysteine; D008315:Malondialdehyde; C027576:4-hydroxy-2-nonenal